强化降压与晕厥、低血压及跌倒:SPRINT随机试验结果
该随机临床试验纳入9361名50岁以上、收缩压130-180 mmHg且心血管高风险但无糖尿病、卒中、症状性心衰、痴呆等情况的成人,比较收缩压目标<120 mmHg与<140 mmHg。年龄与治疗无交互作用。
要点
- 强化降压增加低血压严重不良事件风险(HR=1.67,95%CI 1.21-2.32)。
- 慢性肾病或衰弱者三种结局风险均更高。
核心结论
- 强化收缩压控制组低血压严重不良事件风险更高,晕厥风险可能更高,跌倒风险无差异。
- 强化治疗相关事件风险不随年龄变化。
研究设计与样本
- 随机临床试验,纳入9361名50岁以上、收缩压130-180 mmHg、心血管高风险但无糖尿病、卒中、症状性心衰、射血分数<35%、痴呆或立位收缩压<110 mmHg的成人。
- 干预为收缩压目标<120 mmHg或<140 mmHg。
主要发现
- 慢性肾病或衰弱者三种结局风险均更高。
- 年龄较大与晕厥、低血压、跌倒风险更高相关,但无年龄与治疗的交互作用。
临床怎么用
- 对高龄、慢性肾病或衰弱患者强化降压时,需关注低血压和晕厥风险。
- 强化降压不增加跌倒风险,但个体化评估仍必要。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine predictors of serious adverse events (SAEs) involving syncope, hypotension, and falls, with particular attention to age, in the Systolic Blood Pressure Intervention Trial. DESIGN: Randomized clinical trial. SETTING: Academic and private practices across the United States (N = 102). PARTICIPANTS: Adults aged 50 and older with a systolic blood pressure (SBP) of 130 to 180 mmHg at high risk of cardiovascular disease events, but without diabetes, history of stroke, symptomatic heart failure or ejection fraction less than 35%, dementia, or standing SBP less than 110 mmHg (N = 9,361). INTERVENTION: Treatment of SBP to a goal of less than 120 mmHg or 140 mmHg. MEASUREMENTS: Outcomes were SAEs involving syncope, hypotension, and falls. Predictors were treatment assignment, demographic characteristics, comorbidities, baseline measurements, and baseline use of cardiovascular medications. RESULTS: One hundred seventy-two (1.8%) participants had SAEs involving syncope, 155 (1.6%) hypotension, and 203 (2.2%) falls. Randomization to intensive SBP control was associated with greater risk of an SAE involving hypotension (hazard ratio (HR) = 1.67, 95% confidence interval (CI) = 1.21-2.32, P = .002), and possibly syncope (HR = 1.32, 95% CI = 0.98-1.79, P = .07), but not falls (HR = 0.98, 95% CI = 0.75-1.29, P = .90). Risk of all three outcomes was higher for participants with chronic kidney disease or frailty. Older age was also associated with greater risk of syncope, hypotension, and falls, but there was no age-by-treatment interaction for any of the SAE outcomes. CONCLUSIONS: Participants randomized to intensive SBP control had greater risk of hypotension and possibly syncope, but not falls. The greater risk of developing these events associated with intensive treatment did not vary according to age.
引用
- Sink KM, Evans GW, Shorr RI, et al. Syncope, Hypotension, and Falls in the Treatment of Hypertension: Results from the Randomized Clinical Systolic Blood Pressure Intervention Trial. J Am Geriatr Soc. 2018. PMID: 29601076. doi:10.1111/jgs.15236
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。